Company intelligence / Profile preview

Jin Li

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Jinli Biotech is a China-based biotechnology company primarily focused on the development and manufacturing of biological products and pharmaceutical intermediates. The company specializes in fermentation-based production processes, providing high-quality raw materials and active pharmaceutical ingredients (APIs) for the global healthcare market. Their product portfolio often includes amino acids, vitamins, and specialized biochemicals used in both human and animal health. Jinli Biotech emphasizes research and development to optimize production efficiency and meet international quality standards such as GMP.

Therapeutic areas: Infectious DiseasesMetabolic Disorders
Modalities: Small moleculeBiologic
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Jin Li.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jin Li.

Explore the full profile